Search

everythinglearnresearchcommunity

for

Search:↓

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Ultrasound can safely produce beneficial carrageenan from red algae.

Certain genetic markers can help predict wool production in U.S. sheep.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A mix of sulforaphane, L-menthol, and dexpanthenol could help increase hair growth and reduce hair loss.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.